Medical News Today
Article Date: 23 Oct 2009 - 3:00 PDT
Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the University of Virginia Health System have developed a breakthrough method that could one day eliminate this trial and error approach to treating many cancers.
National Cancer Institute
NCI Cancer Bulletin
September 22, 2009 • Volume 6 / Number 18
Many herbs, dietary supplements, and even vitamins are suspected of interfering with chemotherapy and radiation therapy, and doctors now routinely advise patients who are undergoing cancer treatment to avoid taking these products.
At the same time, cancer researchers have been intrigued by the potent and beneficial biological activity shown by some natural products...
New research details drug therapies in 2009 in Therapeutic Advances in Medical Oncology, published by SAGE
Los Angeles, London, New Delhi, Singapore and Washington DC (August 21, 2009) – Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival...
Mesothelioma.com
Hanover, New Hampshire - August 17, 2009
A new cancer treatment is being investigated by researchers at Dartmouth Medical School and Amtek, both of which are located in Hanover, New Hampshire. The new treatment strategy may offer fresh hope to cancer patients who are fighting off tumors that refuse to respond to traditional treatment options.
The new study was recently published in the open access, peer reviewed journal PLoS ONE. Researchers developed...
ScienceDaily (July 28, 2009) — For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.